Jason T. Maynes

Dr. Maynes completed his graduate degree in Biophysics with doctoral and postdoctoral training at the University of Alberta, University of California Berkeley, Los Alamos National Weapons Lab and Washington University in St. Louis. His clinical training was completed at the University of Alberta, Stanford University and Washington University in St. Louis, moving from St. Louis to Toronto in 2012. His research primarily involves finding new ways to quantify drug action, both therapeutic and toxic, including how to improve the clinical effect of anesthetics and pain medications. His lab has developed new therapies for heart failure, modeling cardiac function using stem-cell derived tissue, and has created platform technologies that measure cardiomyocyte function for the purposes of drug discovery. He holds patents and intellectual property around new therapies for heart failure, novel methods for quantifying cardiomyocyte function and for anti-viral small molecule therapies. His lab is currently funded by the CIHR, NSERC, Canada Foundation for Innovation, The Ontario Research Fund and The Labatt Family Heart Center, in addition to funding from pharmaceutical and venture capital groups